Evonik Functional Solutions GmbH
USPTO PatentsView assignee record - 5 granted patents across 7 technology areas, recorded in grant years 2021–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07C (Acyclic OR Carbocyclic Compounds).
The verdict
According to USPTO PatentsView, Evonik ranks #46,611 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 7 technology areas.
- #46,611
- of 49,997 US assignees by volume
- Top 25%
- by Innovation Score (44.5/100)
- 15.0
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R46611 · Foreign Corporation #46,611 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #46,611/49,997
- PHOTO-FINISH Evodyne Robotics
- CPC-NARROW C07C · 7 areas
- INNOV-PAR 44.5/100
- CLAIMS-RICH 15.0 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2021–2023 · 3y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Evodyne Robotics Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Evonik’s 44.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Evonik
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Evonik Functional… · this assignee
Evonik Functional… · this assignee
45 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Evonik's Innovation Score is 44.5/100 (top 25% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Evonik?
Each dot is one of Evonik’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Evonik’s own 15.0 claims/patent is ABOVE the 14.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Evonik's grants concentrate
Evonik Functional Solutions GmbH is a focused PatentsView assignee: 7 CPC subclasses with 60% of grants classified under C07C (Acyclic OR Carbocyclic Compounds). Peak complete grant year is 2023 (4 grants) versus a trough of 1 in 2021. By volume, Evonik sits between Evodyne Robotics Corporation and Exerkine Corporation.
Evonik's three-year grant acceleration
Evonik Functional Solutions GmbH shows 4 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Evonik's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Evodyne Robotics
Evodyne Robotics Corporation
5 patents
- Evoguard
Evoguard GmbH
5 patents
- Evolutionary Mark…
Evolutionary Markings, LLC
5 patents
- Evondos Oy
Evondos Oy
5 patents
- Excelsys
Excelsys Technologies Ltd.
5 patents
- Exciting
Exciting Inc.
5 patents
- Exela Holdings
Exela Holdings, Inc.
5 patents
- Exerkine
Exerkine Corporation
5 patents
- Evonik Functional… ◀
Evonik Functional Solutions GmbH
5 patents
What this shows Evonik holds 5 patents at rank #46,641, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Evonik
By rank, the assignees closest to #46,641 in granted patent volume.
- Evodyne Robotics Corporation #46,637 · 5 patents
- Evoguard GmbH #46,638 · 5 patents
- Evolutionary Markings, LLC #46,639 · 5 patents
- Evondos Oy #46,640 · 5 patents
- Excelsys Technologies Ltd. #46,642 · 5 patents
- Exciting Inc. #46,643 · 5 patents
- Exela Holdings, Inc. #46,644 · 5 patents
- Exerkine Corporation #46,645 · 5 patents
Leaders in C07C (Acyclic OR Carbocyclic Compounds)
Other assignees with the most granted patents in Evonik's primary technology class.
Evonik's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
45 Top 25% higher than 75% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 1 | 20.0% |
| 2023 | 4 | 80.0% |
Which technologies does Evonik Functional Solutions GmbH patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Evonik Functional Solutions GmbH's patent record in context - here's where to go next.
- Evonik Functional Solutions GmbH's lead technology class is C07C (Acyclic OR Carbocyclic Compounds), 60% of its portfolio - see every assignee active in that class. Explore C07C
- Ranked #46,611 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Evonik Functional Solutions GmbH against Evodyne Robotics Corporation, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 44.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.